Genmab AS - SWOT Analysis - New Research Report on Companies and Markets

2008-07-02 23:45:18 - www.companiesandmarkets.com adds new report - Genmab AS - SWOT Analysis

www.companiesandmarkets.com/Summary-Company-Profile/Genmab-AS-SW ..
Genmab A/S Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Genmab is a biotechnology company engaged in discovery and development of human antibodies for the treatment of life-threatening and debilitating diseases. The

 

 

company’s therapeutic emphasis is on the areas of cancer, infectious disease, rheumatoid arthritis and other inflammatory conditions. It is headquartered in Copenhagen and employs about 250 people. The company recorded revenues of DKK136 million (approximately $23 million) during the fiscal year ended December 2006, an increase of 37.3% over 2005. The operating loss of the company was DKK472 million (approximately $80 million) during fiscal year 2006, a loss of 10.2% over 2005. The net loss in fiscal year 2006 was DKK438 million (approximately $74 million), a loss of 11.1% over 2005.

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available